PTC Therapeutics' Gene Therapy Plans Hit By Pandemic
Ela-Vec Sees EU And US Regulatory Delays
Executive Summary
PTC Therapeutics is one of many companies in the life sciences sector whose regulatory targets have been adversely affected by the coronavirus pandemic.